Physician profile
John Hanna
NPI 1548765464
$932.17
in general payments reported to CMS, 2019-2025
8 companies · $768 in 2025
The $768 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.54 · 2023: $20.78 · 2024: $124 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $484 · Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $484.10 |
| Food and Beverage | $428.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $679.10 | 2025 | 3m Cavilon, Activ.A.C., Kerramax Care |
| Novo Nordisk INC | $131.15 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $35.31 | 2023-2024 | |
| Neurocrine Biosciences, INC. | $19.54 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.22 | 2024 | Farxiga |
| Pfizer INC. | $17.48 | 2024 | |
| Lilly USA, LLC | $16.18 | 2024 | Mounjaro, Zepbound |
| Abbvie INC. | $14.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.